LeMaitre VascularvsThermo Fisher Scientific

LMAT and TMO stock compared: price, dividend, valuation and results, from SEC filings.

LMAT

LeMaitre Vascular, Inc.

$76.87

Value $1.8B

-1.81%
LMAT's page

TMO

Thermo Fisher Scientific Inc

$691.85

Value $257B

-1.20%
TMO's page

LeMaitre Vascular (LMAT) has a market value of $1.8B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, LMAT moved -12.2% and TMO +20.0%. The P/E is 27.7 for LMAT and 36.3 for TMO. Dividend yield: LMAT 1.24%, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LMAT$1.8B

    TMO$257B

    TMO is 147 times LMAT

  • Revenue, 12 months

    LMAT$269M

    TMO$47.4B

    TMO is 176 times LMAT

  • Net income, 12 months

    LMAT$63M

    TMO$7.1B

    TMO is 112 times LMAT

  • Operating margin

    LMAT27.7%

    TMO17.9%

    9.8 points apart

  • ROIC

    LMAT10.1%

    TMO8.2%

    1.9 points apart

  • P/E

    LMAT27.7

    TMO36.3

    TMO is 1.3 times LMAT

  • Dividend yield

    LMAT1.2%

    TMO0.3%

    0.9 points apart

  • 5-year return

    LMAT+46.9%

    TMO+11.0%

    35.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LMAT+46.9%

TMO+11.0%

10015020020222023202420252026
Returns by period
PeriodLMATWith dividendsTMOWith dividends
1 year since November 14, 2025-12.2%Price -13.1%+20.0%Price +19.6%
3 years since November 16, 2023+48.8%+14.2% a yearPrice +45.1%+47.9%+13.9% a yearPrice +46.4%
5 years since November 15, 2021+46.9%+8.0% a yearPrice +40.0%+11.0%+2.1% a yearPrice +9.4%
10 years since November 16, 2016+253.8%+13.5% a yearPrice +221.4%+376.1%+16.9% a yearPrice +362.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LMATLeMaitre VascularTMOThermo Fisher Scientific

Valuation

LMATTMO
Valuation
Price$76.87$691.85
Market value$1.8B$257B
Enterprise value (EV)$1.5B$292B
P/E27.736.3
P/E, 5-year median42.432.7
P/B4.14.7
EV/EBIT20.534.5
Free cash flow yield3.8%3.0%

Results and growth

LMATTMO
Results and growth
Revenue, 12 months$269M$47.4B
Net income, 12 months$63M$7.1B
Free cash flow, 12 months$67M$7.6B
Earnings per share, 12 months$2.75$18.96
Revenue growth, year on year13.5%3.9%
Revenue growth a year, past+14.1%over 5 years+6.7%over 5 years
EPS growth a year, past+19.4%over 5 years+2.1%over 5 years

Margins and returns on capital

LMATTMO
Margins and returns on capital
Gross margin72.0%–
Operating margin27.7%17.9%
Net margin23.5%14.9%
ROIC10.1%8.2%
ROE15.6%13.4%

Balance sheet

LMATTMO
Balance sheet
Cash$390M$6.1B
Total debt$189M$41.4B
Net debt / EBITDA-2.63.7
Interest cover14.4×5.5×

Dividends and buybacks

LMATTMO
Dividends and buybacks
Dividend yield1.2%0.3%
Dividend per share, 12 months$0.95$1.84
Dividend growth a year, past+16.1%over 5 years+14.3%over 5 years
Buyback yield0.1%1.2%
Shareholder yield1.3%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LMAT or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, LeMaitre Vascular or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 146.8 times LeMaitre Vascular ($1.8B), at today's prices.

How did LMAT and TMO stock do over the last 10 years?

Since November 16, 2016, LMAT's price moved +221.4% and TMO's +362.8%. With dividends: LMAT +253.8% (+13.5% a year), TMO +376.1% (+16.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, LMAT or TMO?

The dividend yield at today's price is 1.24% for LeMaitre Vascular and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid $0.95 and $1.84 per share.

What is the P/E of LMAT and TMO?

At today's price, the P/E is 27.7 for LMAT and 36.3 for TMO. The median of the last five years was 42.4 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, LeMaitre Vascular or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 23.5% for LeMaitre Vascular and 14.9% for Thermo Fisher Scientific, and the operating margin 27.7% and 17.9%. Revenue was $269M and $47.4B.

Which is the better investment, LeMaitre Vascular or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.